Genitourinary Cancer
نویسندگان
چکیده
منابع مشابه
Trends of genitourinary cancer among Saudis
INTRODUCTION Saudi Arabia has a low incidence of cancer; the age-standardized rate of cancer is only 83/100,000, compared to the world rate of 181/100,000. Recent reports confirm a yearly increase in cancer in general, and of genitourinary cancer (GUC) in particular. The aim of the study was to assess the trends of GUC among Saudi nationals. METHODS All available annual reports of the Saudi C...
متن کاملRecent advances in immunobiology of genitourinary cancer.
Future success in the management of cancer patients depends to a great extent on the development of means to detect cancer earlier, to stage tumor more accurately, and to monitor its response to treatment. The rapidly expanding field of immunology has provided new ways to approach these problems and offers as well a new modality for the treatment of cancer. The induction of transplantable immun...
متن کاملIncidence estimation of genitourinary cancer in Korea.
A nation-wide study was performed to estimate the incidence of bladder, kidney, renal pelvis and ureter, prostate, testicular and other genitourinary cancer among Koreans in Korea using medical records of the inpatients of the beneficiaries of the Korea Medical Insurance Corporation (KMIC) from Jan. 1, 1989 to Dec. 31, 1989. The crude incidence rate of bladder cancer (ICD-9 188) is estimated to...
متن کاملVaccine and Cancer Therapy for Genitourinary Tumors
Immunotherapy for human cancer has remained in the experimental stage for more than a century. This lengthy duration reflects as much the scope of failures in the area as it does the continuous and remarkable expansion of understanding of immune responses and hosttumor interaction. Immunotherapy for human cancer has largely focused on immunization with peptides or whole antigens, intact tumor c...
متن کاملNovel therapies in genitourinary cancer: an update
In recent years, new treatment for renal cell carcinoma (RCC) has been a spotlight in the field of cancer therapeutics. With several emerging agents branded as 'targeted therapy' now available, both medical oncologists and urologists are progressively more hopeful for better outcomes. The new remedies may provide patients with improved survival and at the same time less toxicity when compared t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Postgraduate Medical Journal
سال: 1985
ISSN: 0032-5473
DOI: 10.1136/pgmj.61.721.1021-a